Results 21 to 30 of about 1,761 (189)

Herpes zoster infection in patients with inflammatory bowel disease [PDF]

The Korean Journal of Internal Medicine
Patients with inflammatory bowel disease (IBD) are at increased risk of herpes zoster (HZ), particularly those receiving immunosuppressive treatments such as corticosteroids, thiopurines, and biologics, which elevate the likelihood of varicella-zoster ...
Dong Hyun Kim, Sang-Bum Kang
doaj   +2 more sources

Herpes zoster mRNA vaccine induces superior vaccine immunity over licensed vaccine in mice and rhesus macaques

Emerging Microbes and Infections
Herpes zoster remains an important global health issue and mainly occurs in aged and immunocompromised individuals with an early exposure history to Varicella Zoster Virus (VZV).
Lulu Huang, Tongyi Zhao, Weijun Zhao, Andong Shao, Huajun Zhao, Wenxuan Ma, Yingfei Gong, Xianhuan Zeng, Changzhen Weng, Lingling Bu, Zhenhua Di, Shiyu Sun, Qinsheng Dai, Minhui Sun, Limei Wang, Zhenguang Liu, Leilei Shi, Jiesen Hu, Shentong Fang, Cheng Zhang, Jian Zhang, Guan Wang, Karin Loré, Yong Yang, Ang Lin   +24 more
doaj   +3 more sources

Research Progress on Varicella-Zoster Virus Vaccines [PDF]

Vaccines
Varicella-zoster virus (VZV) poses significant public health challenges as the etiological agent of varicella (chickenpox) and herpes zoster (HZ), given its high transmissibility and potential for severe complications.
Hongjing Liu, Lingyan Cui, Sibo Zhang, Hong Wang, Wenhui Xue, Hai Li, Yuyun Zhang, Lin Chen, Ying Gu, Tingting Li, Ningshao Xia, Shaowei Li   +11 more
doaj   +2 more sources

Potent and Long-Lasting Immunogenicity Generated by LNP-mRNA gE Antigen Against Varicella Zoster Virus via an AI-Assisted Pipeline. [PDF]

Adv Sci (Weinh)
This study designs a novel mRNA‐LNP vaccine targeting VZV glycoprotein E (gE) for herpes zoster via an AI‐assisted pipeline. Validated in mice and rhesus macaques, the mRNA‐LNP vaccine shows strong humoral and cellular immune responses, with CD4+ T‐cell responses more effective and durable than Shingrix, offering a promising prophylactic option ...
Dong K, Liu F, Wang D, Li Y, Zhang M, Zhou Y, Song G.   +6 more
europepmc   +2 more sources

Delayed inflammatory reaction to hyaluronic acid filler following Shingrix and Fluzone vaccines treated with lisinopril

JAAD Case Reports, 2022
Deirdre Hooper, Girish Gilly Munavalli
exaly   +3 more sources

An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21

npj Vaccines, 2022
Herpes zoster (HZ) is caused by reactivation of latent varicella-zoster virus (VZV) when VZV-specific cellular immunity is insufficient to control reactivation.
Hyo Jung Nam, Sung Jun Hong, Ara Lee, Jiyeon Kim, Sangho Lee, Corey Casper, Darrick Carter, Steven G. Reed, George Simeon, Eui-Cheol Shin   +9 more
doaj   +1 more source

Risk of Guillain-Barré syndrome following herpes zoster, United States, 2010–2018

Human Vaccines & Immunotherapeutics, 2021
Epidemiologic data regarding the risk of Guillain-Barré syndrome (GBS) following herpes zoster (HZ) are limited. We conducted a self-controlled case series analysis using two large national data sources to evaluate the risk of GBS following HZ among U.S.
Tara C. Anderson, Jessica W. Leung, Rafael Harpaz, Kathleen L. Dooling   +3 more
doaj   +1 more source

Projected risks and health benefits of vaccination against herpes zoster and related complications in US adults

Human Vaccines & Immunotherapeutics, 2022
The Advisory Committee on Immunization Practices (ACIP) recommends recombinant zoster vaccine (RZV) to prevent against herpes zoster (HZ) and related complications in immunocompetent adults ≥50 y and immunocompromised adults ≥19 y. In 2019, a statistical
Cara B. Janusz, Tara C. Anderson, Andrew J. Leidner, Grace M. Lee, Kathleen Dooling, Lisa A. Prosser   +5 more
doaj   +1 more source

Herpes Zoster Induced by the Shingrix Vaccine: A Case Report and Literature Review. [PDF]

Cureus
Satow K, Sherer EL, Orlandi A, DeBaene E.   +3 more
europepmc   +3 more sources

National Trends and Disparities in Herpes Zoster Vaccination Among US Older Adults With Diabetes, 2008-2023. [PDF]

Pharmacoepidemiol Drug Saf
ABSTRACT Purpose To evaluate trends and disparities in herpes zoster vaccination among US older adults with diabetes. Methods Data from the 2008 to 2023 National Health Interview Survey were used. Joinpoint regression analysis was performed to analyze trends in herpes zoster vaccination.
Hung CT, Wang LM, Liu DC, Hung YC.
europepmc   +2 more sources